Chronic Cough Market Analysis, Demand And Outlook 2025- 2034


Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

What Is the Growth Potential of the Chronic Cough Market Size Over 2025-2034?
The chronic cough market size has grown strongly in recent years. It will grow from $8.22 billion in 2024 to $8.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to prevalence of underlying respiratory conditions, environmental factors and air pollution, smoking and tobacco use, respiratory infections, allergies and environmental sensitivities.

The chronic cough market size is expected to see strong growth in the next few years. It will grow to " $12.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emerging therapies targeting specific pathways, increasing understanding of reflux-related cough, global efforts in smoking cessation, environmental and occupational health policies. Major trends in the forecast period include advancements in diagnostic technologies, patient-centric approaches, therapeutic innovations in neurogenic cough, telehealth for chronic cough management, research on central sensitization.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp

What Are the Underlying Growth Drivers for the Chronic Cough Market?
The rise in the prevalence of cough is expected to propel the growth of the chronic cough market going forward. Cough refers to a reflex action that, frequently in response to irritation, mucus, or foreign objects, helps clear the airways by ejecting air forcefully from the lungs. A persistent cough that lasts for at least eight weeks is considered chronic. Therefore, when the incidence of cough rises, so do the cases of chronic cough. For instance, in March 2022, according to the Florida Health, a US-based Department of Healthcare, in the US total of 80 patients were found in 2021, for incidences of 41.0 and 1.4 per 100,000 years, respectively. There were 28 pertussis cases recorded in 2023 among 13 countries. Furthermore, in March 2022, according to the Statens Serum Institut, a Denmark-based department of disease surveillance, the number of pertussis cases recorded increased by 41% from November 2022 to April 2023, compared to November 2021–April 2022 in Denmark. Therefore, the rise in the prevalence of cough is driving the growth of the chronic cough market.

How Is the Chronic Cough Market Categorized Based on Key Segments?
The chronic coughmarket covered in this report is segmented –

1) By Drug Class: Antihistamines; Corticosteroids; Decongestants; Combination Drug; Antibiotics; Acid Blockers; Other Drug Classes
2) By Route Of Administration: Oral; Inhalational; Injectable; Other Route Of Administrations
3) By End-Users: Hospitals; Homecare; Specialty Centers; Other End Users
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

Subsegments:
1) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines
2) By Corticosteroids: Inhaled Corticosteroids; Systemic Corticosteroids
3) By Decongestants: Oral Decongestants; Nasal Decongestants
4) By Combination Drug: Antihistamine And Decongestant Combinations; Cough Suppressant And Expectorant Combinations
5) By Antibiotics: Macrolides; Penicillins; Cephalosporins
6) By Acid Blockers: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists
7) By Other Drug Classes: Mucolytics; Cough Suppressants; Herbal Remedies

Which Disruptive Trends Are Reshaping the Competitive Landscape of the Chronic Cough Market?
Major companies operating in the chronic cough market are concentrating on creating innovative products such as biosimilar to strengthen their position in the market. Biosimilars are used to treat conditions like cancer, autoimmune diseases, and diabetes, offering cost-effective alternatives to existing biologics. For instance, in July 2024, according to the Sandoz, a Switzerland-based Pharmaceutical company, launched its biosimilar Pyzchiva (ustekinumab) across Europe, targeting chronic inflammatory diseases such as plaque psoriasis, psoriatic arthritis, and Crohn's disease. This biosimilar is particularly significant as it is the first of its kind available in Europe with all reference medicine strengths, including the initiation dose for Crohn's disease. Developed in partnership with Samsung Bioepis, Sandoz aims to enhance access to effective treatments for millions affected by these conditions. The launch reflects Sandoz's commitment to providing affordable healthcare solutions and improving the quality of life for patients across Europe.

Who Are the Key Strategic Players in the Chronic Cough Market Ecosystem?
Major companies operating in the chronic cough market include Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Glaxo SmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.

Get the detailed chronic cough market report today
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

What Are the Fastest-Growing Regions in the Chronic Cough Market?
North America was the largest region in the chronic cough market in 2024. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more